Dow Up0.11% Nasdaq Up0.12%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.96 Up 0.07(8.38%) 11:41AM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:3.50
Median Target:3.50
High Target:4.00
Low Target:3.00
No. of Brokers:2

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Dec 12, 2013MLV & CoDowngradeBuyHold
Sep 6, 2012Maxim GroupInitiated Buy
May 15, 2012MLV & CoInitiated Buy
Feb 17, 2012Cowen & CoInitiated Neutral
Dec 1, 2011Global Hunter SecuritiesInitiated Buy
Mar 22, 2011Dawson JamesInitiated Buy
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0011
Buy2221
Hold0112
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.